Final results of a single-arm, open-label, multicenter phase 2 study of the radiopharmaceutical [ <sup>177</sup> Lu]Lu-DOTA-TATE and [ <sup>68</sup> Ga]Ga-DOTA-TATE in adults with advanced intracranial meningioma.Sylvia C. Kurz, Timothy Shepherd, David M. Peereboom et al.|Journal of Clinical Oncology|2026Cited by 0